
Montreal, Canada – Arcam AB officials announce that its powder manufacturing subsidiary AP&C in Montreal, Canada, continues to add significant capacity by building three new atomizing reactors. The new capacity increase follows on significant growth in 2015 and a surge in demand for AP&Cs high quality titanium powders.
AP&C continues to build capacity to address the fast growing market for metal powders for additive manufacturing. AP&C’s Plasma technology converts efficiently raw material to powder with excellent key properties such as flowability, density, chemistry, and traceability. With the present build-out AP&C will reach a capacity of at least 500 tons per year.
“The need for high end titanium powder is driven by the fast growth and adoption of additive manufacturing. Arcam is determined to serve the industry through cost efficient solutions thus converting traditional manufacturing into Additive Manufacturing. A requisite is to offer highest quality powder for production at competitive cost,” says Magnus René, CEO of Arcam.
“With this investment we are committing to supply our present and future customers with superior quality materials to meet the high manufacturing standards of the biomedical and aerospace industries. With the new reactors and atomizing technology advancements, AP&C will triple production capacity in 2016,” says Alain Dupont, president of AP&C.
Source: Arcam Group
Latest from Today's Medical Developments
- Worldwide Orthopedic & Spine Contract Manufacturing Market Report 2024-2030
- Streamline your work with Leica's innovative Visoria microscopes
- How Businesses Can Become Proactive, Not Reactive with the M. Ryan Group
- How General Inspection enables Marion Mfg. to ensure zero defects in ECG/EKG electrodes
- Deburring made easy: Innovative hole deburring strategy in hyperMILL 2025
- Navigating the tariff storm: Insights for tech leaders
- Revolutionizing automation: Introducing Vention's MachineMotion AI
- Join the manufacturing community: Upcoming AMT Meetups